Imax (IMAX) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates

20.02.25 01:00 Uhr

Werte in diesem Artikel
Aktien

25,00 EUR -0,40 EUR -1,57%

Indizes

17.804,0 PKT -95,0 PKT -0,53%

Imax (IMAX) reported $92.67 million in revenue for the quarter ended December 2024, representing a year-over-year increase of 7.7%. EPS of $0.27 for the same period compares to $0.17 a year ago.The reported revenue represents a surprise of -11.56% over the Zacks Consensus Estimate of $104.78 million. With the consensus EPS estimate being $0.29, the EPS surprise was -6.90%.While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance.Here is how Imax performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts: Total IMAX System installations: 58 compared to the 62 average estimate based on three analysts. Total System Network (IMAX systems): 1,807 versus 1,776 estimated by two analysts on average. Revenues- Content Solutions: $25.51 million compared to the $28.72 million average estimate based on six analysts. The reported number represents a change of +33.6% year over year. Revenues- All other: $3.12 million versus the six-analyst average estimate of $4.66 million. The reported number represents a year-over-year change of -29.7%. Revenues- Technology Products and Services: $64.04 million compared to the $71.40 million average estimate based on six analysts. The reported number represents a change of +2.5% year over year. Gross Margin- Content solutions: $11.84 million compared to the $15.82 million average estimate based on six analysts. Gross Margin- All Other: $2.31 million versus the six-analyst average estimate of $5.61 million. Gross Margin- Technology Products and Services: $34.22 million compared to the $38.01 million average estimate based on six analysts. View all Key Company Metrics for Imax here>>>Shares of Imax have returned +16.2% over the past month versus the Zacks S&P 500 composite's +2.4% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.Zacks' Research Chief Names "Stock Most Likely to Double"Our team of experts has just released the 5 stocks with the greatest probability of gaining +100% or more in the coming months. Of those 5, Director of Research Sheraz Mian highlights the one stock set to climb highest.This top pick is among the most innovative financial firms. With a fast-growing customer base (already 50+ million) and a diverse set of cutting edge solutions, this stock is poised for big gains. Of course, all our elite picks aren’t winners but this one could far surpass earlier Zacks’ Stocks Set to Double like Nano-X Imaging which shot up +129.6% in little more than 9 months.Free: See Our Top Stock And 4 Runners UpWant the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report IMAX Corporation (IMAX): Free Stock Analysis ReportTo read this article on Zacks.com click here.Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks

Ausgewählte Hebelprodukte auf IMAX

Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf IMAX

NameHebelKOEmittent
NameHebelKOEmittent
Wer­bung

Quelle: Zacks

Nachrichten zu IMAX Corp.

Wer­bung

Analysen zu IMAX Corp.

DatumRatingAnalyst
25.02.2019IMAX HoldCanaccord Adams
27.04.2018IMAX BuyThe Benchmark Company
28.02.2018IMAX BuyB. Riley FBR, Inc.
30.10.2017IMAX OutperformBarrington Research
12.07.2017IMAX Mkt PerformBarrington Research
DatumRatingAnalyst
27.04.2018IMAX BuyThe Benchmark Company
28.02.2018IMAX BuyB. Riley FBR, Inc.
30.10.2017IMAX OutperformBarrington Research
21.04.2017IMAX OutperformWedbush Morgan Securities Inc.
22.04.2016IMAX BuyMKM Partners
DatumRatingAnalyst
25.02.2019IMAX HoldCanaccord Adams
12.07.2017IMAX Mkt PerformBarrington Research
07.06.2017IMAX HoldThe Benchmark Company
03.05.2011IMAX holdStifel, Nicolaus & Co., Inc.
12.01.2006IMAX abwartenDer Aktionär
DatumRatingAnalyst

Keine Analysen im Zeitraum eines Jahres in dieser Kategorie verfügbar.

Eventuell finden Sie Nachrichten die älter als ein Jahr sind im Archiv

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für IMAX Corp. nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"
mehr Analysen